Free Trial

Hamilton Lane (NASDAQ:HLNE) Given New $145.00 Price Target at JPMorgan Chase & Co.

Hamilton Lane logo with Finance background

Hamilton Lane (NASDAQ:HLNE - Free Report) had its price objective lowered by JPMorgan Chase & Co. from $153.00 to $145.00 in a report released on Wednesday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock.

HLNE has been the topic of a number of other research reports. Wells Fargo & Company upped their price target on Hamilton Lane from $161.00 to $162.00 and gave the stock an "equal weight" rating in a report on Friday, July 11th. Keefe, Bruyette & Woods lowered their target price on Hamilton Lane from $162.00 to $155.00 and set a "market perform" rating on the stock in a report on Monday, June 2nd. Wall Street Zen downgraded Hamilton Lane from a "hold" rating to a "sell" rating in a research note on Friday, June 6th. Morgan Stanley dropped their target price on shares of Hamilton Lane from $190.00 to $157.00 and set an "equal weight" rating for the company in a report on Monday, April 14th. Finally, Oppenheimer downgraded shares of Hamilton Lane from an "outperform" rating to a "market perform" rating in a report on Thursday, May 15th. Two research analysts have rated the stock with a sell rating and six have given a hold rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $161.29.

Get Our Latest Analysis on Hamilton Lane

Hamilton Lane Stock Performance

Shares of Hamilton Lane stock traded up $1.05 during trading on Wednesday, reaching $156.57. The company's stock had a trading volume of 274,084 shares, compared to its average volume of 726,071. The company has a 50-day moving average price of $151.20 and a two-hundred day moving average price of $151.20. Hamilton Lane has a fifty-two week low of $123.98 and a fifty-two week high of $203.72. The firm has a market cap of $8.38 billion, a PE ratio of 29.05 and a beta of 1.22. The company has a current ratio of 4.83, a quick ratio of 4.83 and a debt-to-equity ratio of 0.31.

Hamilton Lane (NASDAQ:HLNE - Get Free Report) last announced its earnings results on Thursday, May 29th. The company reported $1.21 EPS for the quarter, beating analysts' consensus estimates of $1.20 by $0.01. The business had revenue of $197.97 million during the quarter, compared to analysts' expectations of $165.49 million. Hamilton Lane had a net margin of 30.50% and a return on equity of 32.94%. The business's revenue was up 12.1% compared to the same quarter last year. During the same period in the prior year, the company earned $1.38 earnings per share. On average, analysts forecast that Hamilton Lane will post 4.97 EPS for the current year.

Hamilton Lane Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, July 7th. Shareholders of record on Friday, June 20th were issued a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.38%. This is a boost from Hamilton Lane's previous quarterly dividend of $0.49. The ex-dividend date was Friday, June 20th. Hamilton Lane's dividend payout ratio is 40.07%.

Hedge Funds Weigh In On Hamilton Lane

Institutional investors have recently made changes to their positions in the stock. GAMMA Investing LLC lifted its position in Hamilton Lane by 65.8% in the 1st quarter. GAMMA Investing LLC now owns 920 shares of the company's stock valued at $137,000 after purchasing an additional 365 shares during the last quarter. OneDigital Investment Advisors LLC bought a new stake in Hamilton Lane during the first quarter worth approximately $225,000. Mirae Asset Global Investments Co. Ltd. increased its position in shares of Hamilton Lane by 12.5% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 9,773 shares of the company's stock valued at $1,437,000 after purchasing an additional 1,084 shares during the period. Wealth Enhancement Advisory Services LLC raised its stake in shares of Hamilton Lane by 6.6% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 3,414 shares of the company's stock worth $508,000 after buying an additional 212 shares in the last quarter. Finally, New York State Teachers Retirement System raised its stake in shares of Hamilton Lane by 11.3% in the 1st quarter. New York State Teachers Retirement System now owns 7,880 shares of the company's stock worth $1,172,000 after buying an additional 800 shares in the last quarter. 97.40% of the stock is owned by institutional investors.

Hamilton Lane Company Profile

(Get Free Report)

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

Read More

Analyst Recommendations for Hamilton Lane (NASDAQ:HLNE)

Should You Invest $1,000 in Hamilton Lane Right Now?

Before you consider Hamilton Lane, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hamilton Lane wasn't on the list.

While Hamilton Lane currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines